Consensus ESG Ratings
Member Sign In
ESG News For Ocular Therapeutix Inc
These sites contributed news to this page:
-
BeiGene Receives FDA Approval for TEVIMBRA® for the Treatment of Advanced or Metastatic Esophageal Squamous Cell Carcinoma After Prior Chemotherapy
Results from the global, Phase 3 RATIONALE 302 trial showed TEVIMBRA prolonged the survival of patients who received prior systemic treatment compared to chemotherapyApproval represents the first indication in the U.S. for TEVIMBRA -
Lions Eye Institute and RTI Donor Services Expand Strategic Relationship to Maximize the Gift of Tissue Donation
The Lions Eye Institute for Transplant and Research (LEITR), a nonprofit organization dedicated to the recovery, evaluation and distribution of eye tissue, and RTI Donor Services, Inc. (RTIDS), a nonprofit organization dedicated to providing responsible stewardship of the gift of tissue donation, announced an expanded relationship to increase efficiencies in tissue donation and enhance patients’ lives. Through this relationship, each partner will focus on its